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Background
Ischemic heart disease is a major cause of morbidity and mortality throughout the world. With an aging population, older patients are increasingly being considered for surgical revascularization.
Conventional coronary artery bypass surgery (CCABG), performed on cardiopulmonary bypass, is one of the most commonly performed procedures and a very well established treatment for ischemic heart disease. Theoretical considerations and results from retrospective studies have suggested that post-operative morbidity may be diminished when coronary artery bypass surgery is performed without the use of cardiopulmonary bypass (Off-Pump Coronary Artery Bypass; OPCAB). Advances in surgical techniques, the use of intracoronary shunts, and improvements in epicardial stabilization devices have allowed surgeons to routinely perform multi-vessel OPCAB.
During the last decade, several randomized, controlled trials have addressed the clinical outcomes of CCABG and OPCAB. Differences in postoperative atrial fibrillation, blood transfusion, release of biochemical markers of myocardial damage, and length of hospitalization have seemed to favor OPCAB. 1, 2 On the other hand, some studies have shown that patients operated using OPCAB have higher risk of incomplete revascularization and graft failure than patients operated with CCABG. [3] [4] [5] [6] The question whether OPCAB prevents postoperative cognitive dysfunction, stroke and other organ dysfunction remains controversial. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The recent ROOBY-trial, comprising 2203 mainly younger patients showed better long term outcome of CCABG than of OPCAB. 6 Studies comparing self-assessed symptoms and quality of life (QoL) in younger patients have failed to show a significant benefit of one method over another. [11] [12] [13] [14] Age is an independent predictor of major complications after cardiac surgery. Several authors have claimed that the benefits of OPCAB are more pronounced in elderly patients and patients with high co-morbidity. [15] [16] [17] [18] [19] [20] In the previous trials, high-risk groups, e.g. elderly patients
and patients with multiple vessel disease, are under-represented. We, therefore, aimed to perform a large-scale randomized controlled trial to compare the outcomes of CCABG and OPCAB in patients aged 70 and above. Since CCABG is very well described and validated in previous literature, we aimed to assess non-inferiority of OPCAB relative to CCABG.
Methods
Design and participants
Details of the design of the DOORS-study have been given elsewhere. 21 The territory, indicating a higher total number of OPCAB-procedures.
Consent and inclusion procedure
The patients gave written consent after written and oral information. The study protocol was approved by the local ethics committee.
Randomization and masking
On-line randomization was performed. Block randomisation was performed 1:1 in blocks of six stratified by treating center. Treatment was not masked.
Interventions
Anaesthesia, cardiopulmonary bypass, surgery and postoperative care were performed according to detailed protocols. 21 All operations were performed through a full, median sternotomy, and all patients in the CCABG group were operated with aortic cross-clamping and cardioplegic arrest.
Graft patency was assessed per-operatively via a Transit Time Flow Meter (Medistim, Oslo, Norway). All patients were treated with clopidogrel 75 mg per day for three months postoperatively, except patients treated with coumarin for other reasons. Statins and salicylic acid were given to all patients unless specifically contraindicated.
Follow-up
Patient characteristics, intraoperative and postoperative data were prospectively recorded.
Patients with symptoms and signs of stroke or transient cerebral ischemia were assessed by a neurologist. Patients suspected of stroke or transient cerebral ischemia had a magnetic resonance diffusion scan performed immediately or a computed tomography scan 3-7 days after the onset of symptoms. Electrocardiogram, creatinine-kinase MB, and troponine-T were obtained one day prior to operation, 6-12 hours, 16-24 hours, and 4 days postoperatively. All patients had an electrocardiogram performed 30 days postoperatively. If a patient had been transferred to another hospital or readmitted to a hospital during the 30 days of follow-up, files and relevant computed tomography scans, electrocardiograms, and biochemical tests were retrieved.
A blinded endpoint committee, including two cardiologists, two neurologists, and one cardiac surgeon not otherwise connected to the study, assessed the data individually.
Discrepancies were solved by conference in accordance to predefined definitions of stroke and myocardial infarction as described earlier. 21 All patients were asked to fill in a booklet containing QoL-questionnaires the day before surgery. Six months later, an identical booklet was sent to the patients. Patients who did not respond initially were reminded once either by mail or by telephone.
Two instruments were designed to assess QoL (SF-36, Danish version, 22 and
EuroQol/EQ5D, Danish version 23 ). Six months follow-up of survival was performed through the Danish National Registry.
Statistics
The incidence of the primary, combined endpoint, i.e. mortality, myocardial infarction, or stroke within 30 days postoperatively, was estimated to be 8%. This estimate was based on literature as well as on data from Vestdansk Hjertedatabase, a cardiac surgical database covering 60% of all cardiac procedures in Denmark. Based on earlier, observational studies of elderly patients undergoing coronary revascularization, [15] [16] [17] [18] [19] [20] we hypothesized that this incidence could be reduced to 4% by avoiding cardiopulmonary bypass. With a margin of 0.5% in risk difference for a test of non-inferiority of OPCAB compared to CCABG, a statistical power of 82% could be achieved by including 900 evaluable patients. It was expected that all patients that were randomized would be available for evaluation. Because of the relatively low incidence of severe complications to coronary artery by-pass surgery the statistical power was only anticipated to allow for assessment of non-inferiority rather than superiority of OPCAB relative to CCABG.
For the primary, combined endpoint, a one-sided Farrington-Mannings' test of noninferiority test on risk difference with a pre-specified margin of 0.5 % was used. For comparison of baseline characteristics and secondary endpoints, Student´s T test (T), Pearsons chi-square (P),
Mann-Whitneys ranktest (r), or Fisher´s exact test (F) were used as appropriate. Ninety-five percent confidence intervals (CIs) for risk differences were calculated using a normal approximation with standard errors corresponding to the observed frequencies. For consistency CI for the primary endpoint, was calculated using the Farrington-Manning approach.
Comparisons of quality-of-life data were performed using a paired Student´s T-test comparing preoperative values with postoperative values within treatment groups and OPCAB values with CCABG values both preoperatively and postoperatively.
A p-value below 0.05 was considered significant with the exception of non-inferiority, where the one-sided p-value below 0.025 was considered significant (i.e., non-inferiority would be met). Analyses were performed according to intention to treat using STATA (StataCorp LP, Lakeway Drive, College Station, TX 77845, USA).
Role of funding sources
The sponsors of this trial were not involved in study design, data collection, data analysis, data interpretation, or writing of the report.
Results
From January 1 st 2005 to November 16 th 2008 a total of 1708 patients were screened, of which 900 patients were randomly assigned to either CCABG or OPCAB.
There was no significant difference between groups with regard to age, sex, or preoperative morbidity ( Table 1) .
From a total number of 450 in each group, 389 (86%) of the patients randomized to receive OPCAB and 429 (95%) of the patients randomized to receive CCABG were operated according to protocol (Figure 1 ). A total of thirteen patients were excluded from per-protocol treatment between randomization and operation. The reasons for this change in strategy were revision of the decision to operate (n=5), withdrawal of consent (n=2), logistic reasons (n=5), or death (n=1). Seven of these patients were operated, either on-pump or off-pump, by surgeons who were not involved in the study. Three of these seven patients were randomized to OPCAB, but received CCABG. Fifty-seven other operations were converted from off-pump to on-pump intraoperatively because of hemodynamic instability (n=27) or difficulties with exposure of coronary vessels (n=30). Twelve patients had their operations converted from CCABG to OPCAB, all because of heavily calcified aortas. All of the above mentioned patients were still included in the intention to treat analysis.
Follow up for evaluation of the primary end-point was complete in all patients at 30 days and six months follow-up. Due to weak or inconclusive data at 30 days follow up, the end-point committee was not able to reach a conclusion with regard to stroke in one patient, and with regard to myocardial infarction in three patients. Statistically, these four patients were treated as not having suffered strokes or myocardial infarctions, respectively. At six months follow-up, 798
of the surviving 860 patients (93%) returned the booklet of questionnaires.
Baseline-and peri-operative data are given in Table 2 . Patients in the OPCAB group received a mean of 2.9 (1.0) grafts as compared to 3.1 (0.93) grafts in the CCABG group (p=0.007). Blood loss during surgery and within the first 24 postoperative hours was significantly higher among patients in the OPCAB group despite routine use of cell-saver. No significant difference was, however, detected in the use of blood products. There was a trend towards longer ICU-stay for the CCABG-patients causing a significant difference using the Mann-Whitneys rank test (p=0.046), despite similar median stay (22 hours) in both groups.
Thirty days follow-up with endpoints assessed by the blinded endpoint committee are given in Table 3 . Proportion of patients experiencing a composite endpoint within 30 days was 10.2% for CCABG and 10.7 % for OPCAB. Implied risk difference of 0.4 % with a CI of (-3.6 %; 4.4 %) showed non-significance in a standard test for equality (p=0.82) as well as for noninferiority with an inferiority margin of 0.5 % as defined in the trial protocol (p=0.49) 21 . Nor were any statistically significant differences observed in the incidence of death, stroke or myocardial infarction, although trends were observed toward fewer strokes but more myocardial infarctions in the off-pump group.
No deaths, but 7 myocardial infarctions and three strokes representing a total of 8 composite endpoints was observed among the sixty patients converted from OPCAB to CCABG.
Twenty-seven of these patients were converted because of hemodynamic instability. Among the latter group three myocardial infarctions and one stroke occurred. In three cases the decision to perform CCABG in a patient randomized to OPCAB was made pre-operatively because no certified surgeon was available. One of these three patients suffered a myocardial infarction and died within 30 days. Among the patients converted from CCABG to OPCAB, one suffered a stroke and one suffered a myocardial infarction.
Among the randomized patients, 90 were 80 years or above. Forty-one were included in the CCABG-group and 49 in the OPCAB group. In these groups, one patient randomized to CCABB and three patients randomized to OPCAB died within thirty days (p=0.62), One patient of this age group and randomized to CCABG, suffered a stroke compared to two OPCAB-patients (p=1.00). Three patients in the CCABG-group and 9 OPCAB-patients age 80 or above suffered a myocardial infarction (p=0.21). The combined end point of death and/or stroke and/or myocardial infarction occurred in 16 octogenarian patients, distributed with 11 in the OPCAB group and 5 in the CCABG group (p=0.27).
Six months after surgery, mortality was 21 (4.7%) in the on-pump group and 19 (4.2%) in the off-pump group (p=0.75). Thirty days and six months mortality among the screened patients, who did not end up participating in the study were 4.2% and 7.4 %, respectively (p<0.01 for both periods compared to participating patients). Improvement in self-assessed, health-related QoL was demonstrated. However, no significant differences between OPCAB and CCABG patients were demonstrated ( Table 4) .
Discussion
This study is the largest randomized comparison between CCABG and OPCAB specifically focusing on elderly patients. All patients included were over the age of 70 and had a mean EuroScore above 5, implying a moderate to high risk population.
Previous studies have either focused on low risk-or non-selected patients, and in all studies elderly, high-risk patients have been underrepresented. This is especially unfortunate since these groups have been purported to benefit the most from avoiding cardiopulmonary bypass. The lack of a significant difference in mortality or major morbidity reported in previous trials could, theoretically, be due to the few endpoints reached in predominantly low risk patients in studies comprising relatively small numbers of younger patients. The fact that the ROOBY trial 6 showed better outcomes after 12 months in the CCABG group could, theoretically, have been explained by the fact that the younger patients included in this trial did not benefit as much from avoiding cardiopulmonary bypass as older patients would, while a slightly lower number of grafts in the OPCAB group increased postoperative risk.
The mortality in the present study was lower than predicted by EuroScore with no significant difference either at 30 days or at six months follow-up. Overall mortality was acceptable compared to earlier studies although we included patients with a higher risk.
Although there was a trend towards higher incidence of acute myocardial infarction in the OPCAB group, this difference did not reach statistical significance. Most of the infarctions occurred during the first twenty-four hours after the beginning of surgery (94%), but it is not possible from the current data to tell whether the trend was due to the lower number of grafts, graft occlusion, or poorer myocardial protection in the OPCAB group. Categorizing patients as treated instead of intention-to-treat turns the observed risk of composite endpoint against CCABG (Table 5 ). However, as converted patients are highly selected, no interpretation or statistical testing of these figures appears reasonable.
In non-randomized comparisons, earlier investigators have found an OPCAB approach to be especially beneficial in octogenarians (17) (18) (19) . In the present study, we chose to study a broader age group including all patients above seventy. This choice was made partly because of the wish to provide evidence that would be relevant to a larger proportion of future patients, and partly because of limited availability of patients above 80 years old. Hence, statistical power was not sufficient to evaluate differences in outcome for this specific group in the present study. The post-hoc analysis described above, however, shows a trend that rather points towards a worse than towards a better outcome for octogenarian OPCAB-patients in the current setting.
The overall number of myocardial infarctions was higher than the ones reported in previous trials. This difference may be caused by a tighter monitoring of both electrocardiographic and biochemical markers of myocardial damage, although the exact level of follow-up seldom is reported in earlier trials. The definition of myocardial infarction used in the present study also included patients with isolated release of biochemical markers, and not only patients with Q-wave infarctions as in some of the previous studies 5 . The age of the participating patients, previously shown as independent predictors of peri-operative myocardial damage, 24 was higher in this study than in most of the previous ones. In addition, the study was performed in an environment with a high proportion of per-cutaneous revascularizations. 26 This reality suggests that the patients involved in the present study had advanced coronary disease and complex coronary anatomy.
Off-pump surgery has been suggested to decrease the risk of stroke. Although only seen as trends in earlier trials, the difference has reached statistical significance in a recent metaanalysis. 10 However, the ROOBY trial, comprising a high proportion of the total number of randomized patients, showed a trend in the opposite direction. 6 In the present study, more strokes occurred in the on-pump group, although the difference was not statistically significant (p=0.12).
Clamping may have affected the risk of stroke after OPCAB. The protocol left the use of epiaortic ultrasound, side-biting clamp, double clamping, Heart-string device or no-touch aorta to the surgeon´s discretion. Although only 27% of OPCAB-operations were performed using a side-biting clamp, this group represented a substantial part of the strokes suffered by OPCABpatients. Among the 10 patients randomized to OPCAB who suffered a stroke, three had been converted to on-pump peri-operatively, five were operated using a side-biting clamp. One patient, operated using a Heart String -device, suffered a stroke on the third postoperative day after electroconversion of atrial fibrillation. Another patient operated with no-touch aorta technique suffered a stroke 28 days after surgery. No cardiac cause for this stroke was suspected.
The proportion of on-pump patients, who suffered a stroke in the present study, was 4.0 %, which is higher than the 3.2% weighted average reported in a meta-analysis of observational studies, although lower than in some of the individual studies reported in this review 16 .
Procedures that might have decreased the stroke rate s.a. preoperative screening of high-risk patients using carotid ultrasound and peri-operative epi-aortic ultrasound were not part of the study protocol and only performed at the individual surgeon´s discretion. This may have influenced the overall stroke rate in the study. Also, a more meticulous follow-up performed in a prospective study compared to retrospective data acquisition, may potentially have allowed a higher proportion of late strokes and small strokes to be identified.
When comparing OPCAB and CCABG in clinical trials, much discussion has related to surgeon experience. Excellent results have been reported in trials with only one or a few highly dedicated off-pump surgeons, whereas lower graft patency rates are reported by others. The present study included the results from twelve surgeons from four different centers, all with intermediary experience in OPCAB (Appendix). All participating surgeons were consultants, and, as opposed to the ROOBY trial, residents were never the primary surgeon at an operation.
Prior to participation in the present study, the surgeons needed to have performed twenty-five off-pump operations with anastomoses to the obtuse marginal branches of the circumflex artery, usually implying a higher number of OPCAB procedures with grafts only to the anterior left or right ventricular wall. Nevertheless, all participating surgeons had more experience in on-pump surgery, and a learning curve may have influenced the results.
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In conclusion, we found no major advantage in using OPCAB in elderly patients with regard to major morbidity or self-assessed, health-related QoL and non-inferiority relative to CCABG with regard to the primary composite end-point was not proven. Both techniques are relatively safe and can be performed with a fairly low rate of major complications in patients with high age and co-morbidities. In the editorial accompanying the publication of the ROOBYtrial, it was suggested that [OPCAB is] "...a technique reserved for selected patients and skilled surgeon advocates". 27 Although this is, ideally, true for any kinds of operations, the results of the present study do not prove OPCAB to be inferior to CCABG when applied to a general, elderly population. The short to intermediate follow-up in the present study mainly elucidates the comparative safety of the operations. The relative efficacy will be dependent on graft patency and will need to be evaluated by a longer period of follow-up.
Limitations of study
The present study is larger than most of the previous trials, only surpassed by the ROOBY-trial 6 .
The statistical strength of the study is further enhanced by the inclusion of intermediate and highrisk patients which have been underrepresented in earlier trials. Still, because of the relatively low incidence of severe complications to coronary artery by-pass surgery -whether performed with or without the use of cardiopulmonary bypass -the statistical power was only anticipated to allow for assessment of non-inferiority rather than superiority of OPCAB relative to CCABG.
This was still considered relevant since CCABG is so well described and validated. When introducing an alternative treatment, like OPCAB, we found that it would require a test of noninferiority. Still, mainly due to the unexpectedly high number of myocardial infarctions in the OPCAB-group, a definite conclusion with regard to non-inferiority of OPCAB could not be reached. Given the equality of trends it seems unlikely that even a much higher number of included patients would have proven one treatment superior to the other in the current setup.
While a reduction of complication rate of 50%, as assumed in the power-calculation, may seem overly optimistic in retrospect, this was realistic based on the results from similar patient groups published at the time of the planning of the present study. [15] [16] [17] [18] [19] [20] Patients and professionals were not blinded with regard to treatment as this was considered impractical. Only one of the previous trials, with only one participating centre and only one surgeon 2 managed to do this. The end-point committee was however, blinded.
The thirteen percent conversion rate from OPCAB to CCABG is higher than reported in studies with only one or a few highly dedicated OPCAB surgeons. It is, however, at the same level as in the ROOBY trial which was performed in a population with much lower perioperative risk. This finding, together with a mortality rate well below the one predicted by Euroscore, indicates that the safety of the procedures was acceptable. Nevertheless, we recognize that risk reducing strategies, including a consequent "no-touch aorta" strategy, may have limited the number of strokes in the OPCAB group. Also, although, as described above, some experience in both techniques was required from the participating consultants, the learning curve may imply that better results could be obtained with more experience.
The present report does not include data on long-term morbidity and mortality. Further follow-up and angiographic control of graft patency are, however, planned and in the process of being performed. 8.1 (7.2) 7.6 (8.0) 0.38 (P) Data are number (%), or median and range (m(r)). Tests are Pearsons chi-square (P), Mann-Whitneys ranktest (r) or T-test (T). All values are given according to the original intention-to-treat. *Patients for whom the strategy to operate was changed before operation or who died before operation Six patients did not receive any operation. One patient, randomized to OPCAB, died before operation. In the other five cases, the decision to operate was revised after randomization. Coronary Artery Bypass. *Among the 129 patients excluded from the study by the operating surgeon, the reasons were "participation in other study", n=26, "revision of the decision to operate (e.g. favouring PCI)", n=15, "decision on concomitant other cardiac surgery (valve or Maze) to be made peri-operatively" n= 16, "surgeon finds that the patient is better operated with OPCAB" n =29, "surgeon finds that the patient is better operated with CCABG", n=21. Other reason, why the surgeon did not find the patient suitable for participation e.g. "patient too frail to be asked" n=22.
